World Of Taxonomy
C205404Level 4

Bevacizumab/Cyclophosphamide/Pembrolizumab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of bevacizumab, oral cyclophosphamide and pembrolizumab that can be used for the treatment of ovarian, fallopian tube, and primary peritoneal cancers.

**Synonyms:** - Avastin/Cyclophosphamide/Keytruda - Bevacizumab-Cyclophosphamide-Pembrolizumab - Bevacizumab/Cyclophosphamide/Pembrolizumab - Bevacizumab/Oral Cyclophosphamide/Pembrolizumab - Oral Cyclophosphamide Plus Bevacizumab Plus Pembrolizumab - Oral Cyclophosphamide/Bevacizumab/Pembrolizumab

GET/api/v1/systems/nci_thesaurus/nodes/C205404
Official DownloadCC BY 4.0Source

Hierarchy Explorer

Loading...

Cross-system equivalences0

No cross-system equivalences mapped for this node.